|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.750 AUD | +0.36% |
|
-8.03% | +4.58% |
| Capitalization | 31.63B 20.61B 17.75B 16.51B 15.39B 28.28B 1,772B 200B 75.68B 829B 77.3B 75.7B 3,068B | P/E ratio 2026 * |
45x | P/E ratio 2027 * | 38.5x |
|---|---|---|---|---|---|
| Enterprise value | 32.78B 21.36B 18.39B 17.12B 15.95B 29.31B 1,837B 207B 78.44B 859B 80.11B 78.46B 3,180B | EV / Sales 2026 * |
3.48x | EV / Sales 2027 * | 3.21x |
| Free-Float |
84.72% | Yield 2026 * |
1.38% | Yield 2027 * | 1.6% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sigma Healthcare Limited
More press releases
More news
| 1 day | +0.36% | ||
| 1 week | -4.84% | ||
| Current month | -8.03% | ||
| 1 month | -15.12% | ||
| 3 months | -8.03% |
| 1 week | 2.7 |  | 2.91 |
| 1 month | 2.7 | | 3.27 |
| Current year | 2.64 | | 3.32 |
| 1 year | 2.64 | | 3.32 |
| 3 years | 2.64 | | 3.32 |
| 5 years | 2.64 | | 3.32 |
| 10 years | 2.64 | | 3.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 54 | 2022-01-31 |
Mark Conway
DFI | Director of Finance/CFO | - | 2023-10-31 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Sammells
CHM | Chairman | - | 2022-07-05 |
Vikesh Ramsunder
BRD | Director/Board Member | 54 | 2022-01-31 |
Neville Mitchell
BRD | Director/Board Member | 66 | 2023-02-01 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.36% | -4.84% | - | - | 20.61B | ||
| -0.66% | -1.84% | +22.92% | +115.40% | 88.93B | ||
| -0.41% | -2.09% | +71.77% | +191.65% | 38.43B | ||
| +0.42% | +3.47% | +46.66% | -11.76% | 9.9B | ||
| -0.73% | +5.61% | -1.09% | +7.53% | 8.82B | ||
| -1.07% | +0.54% | -3.64% | -0.86% | 7.44B | ||
| +0.43% | +0.17% | +16.80% | +14.53% | 5.48B | ||
| +0.96% | +1.59% | -12.82% | -7.94% | 5.13B | ||
| 0.00% | +0.76% | +16.28% | +3.73% | 4.83B | ||
| -1.82% | +2.86% | +15.88% | +25.70% | 3.75B | ||
| Average | -0.09% | -0.48% | +19.19% | +37.55% | 19.33B | |
| Weighted average by Cap. | -0.07% | -2.40% | +31.19% | +102.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.41B 6.13B 5.28B 4.91B 4.58B 8.41B 527B 59.53B 22.51B 247B 22.99B 22.52B 913B | 10.12B 6.59B 5.68B 5.28B 4.92B 9.05B 567B 64.03B 24.22B 265B 24.73B 24.22B 982B |
| Net income | 691M 450M 388M 361M 336M 618M 38.74B 4.37B 1.65B 18.12B 1.69B 1.65B 67.07B | 815M 531M 457M 426M 396M 729M 45.67B 5.16B 1.95B 21.36B 1.99B 1.95B 79.07B |
| Net Debt | 1.15B 750M 646M 601M 560M 1.03B 64.53B 7.29B 2.76B 30.19B 2.81B 2.76B 112B | 867M 565M 487M 453M 422M 775M 48.58B 5.49B 2.07B 22.73B 2.12B 2.08B 84.12B |
More financial data
* Estimated data
Employees
20,000
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-16 | 2.750 $ | +0.36% | 25,427,672 |
| 25-07-15 | 2.740 $ | -2.49% | 26,596,260 |
| 25-07-14 | 2.810 $ | -1.75% | 12,839,840 |
| 25-07-11 | 2.860 $ | +0.35% | 9,287,681 |
| 25-07-10 | 2.850 $ | -1.38% | 13,902,910 |
Delayed Quote Australian S.E., July 16, 2025 at 02:21 am
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
2.740AUD
Average target price
2.964AUD
Spread / Average Target
+8.18%
Annual profits - Rate of surprise
- Stock Market
- Equities
- SIG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition